New research published in eNeuro finds that inhaled CBD may help slow Alzheimer's disease by reducing chronic brain inflammation, a process increasingly recognized as a key driver of nerve cell damage. Scientists at Augusta University tested CBD in Alzheimer's mice and found it lowered activity of multiple inflammatory regulators and reduced pro-inflammatory molecules in the central nervous system. Notably, the lead researcher points to earlier work showing CBD can also help clear amyloid plaques and tau tangles through a separate mechanism, suggesting CBD could attack Alzheimer's on at least two fronts simultaneously. While results are promising, the study was conducted in mice and human clinical trials are still needed before any therapeutic conclusions can be drawn.
